Himmelfarb Health Sciences Library, The George Washington University

Health Sciences Research Commons
Pediatrics Faculty Publications

Pediatrics

2017

Transvenous nonfluoroscopic pacemaker
implantation during pregnancy guided by
3-dimensional electroanatomic mapping
Jacob Hartz
Bradley C. Clark
George Washington University

Seiji Ito
Elizabeth D Sherwin
George Washington University

Charles I Berul
George Washington University

Follow this and additional works at: https://hsrc.himmelfarb.gwu.edu/smhs_peds_facpubs
Part of the Cardiovascular Diseases Commons
APA Citation
Hartz, J., Clark, B. C., Ito, S., Sherwin, E., & Berul, C. (2017). Transvenous nonfluoroscopic pacemaker implantation during pregnancy
guided by 3-dimensional electroanatomic mapping. HeartRhythm Case Reports, (). http://dx.doi.org/10.1016/j.hrcr.2017.07.020

This Journal Article is brought to you for free and open access by the Pediatrics at Health Sciences Research Commons. It has been accepted for
inclusion in Pediatrics Faculty Publications by an authorized administrator of Health Sciences Research Commons. For more information, please
contact hsrc@gwu.edu.

Transvenous nonﬂuoroscopic pacemaker implantation
during pregnancy guided by 3-dimensional
electroanatomic mapping
Jacob Hartz, MD, MPH, Bradley C. Clark, MD, Seiji Ito, MD, Elizabeth D. Sherwin, MD, FHRS,
Charles I. Berul, MD, FHRS
From the Division of Cardiology, Children’s National Health System, George Washington University School
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Introduction
Patients with congenital heart disease are at ongoing risk of
developing both bradyarrhythmias and tachyarrhythmias decades after surgical repair. Rarely, arrhythmias can be exacerbated during pregnancy and require emergent
intervention. Here, we report unique experience with nonﬂuoroscopic pacemaker implantation during pregnancy.
Ionizing radiation, even in low doses, is associated with an
increased risk of malignancy, and a fetus may be at particularly increased risk.1,2 Over the past 2 decades, the use of
ﬂuoroscopy in cardiac ablation procedures has become
nearly obsolete with the development of 3-dimensional
(3D) electroanatomic mapping software such as CARTO
(Biosense-Webster, Diamond Bar, CA) and NavX or EnSite
(St. Jude Medical, Inc., St. Paul, MN).3 However, certain procedures, such as device implants, still commonly use ﬂuoroscopy in most instances.2 Fluoroscopy use in patients with
congenital heart disease is of utmost concern because of cumulative radiation exposure from multiple lifetime catheterization, radiographic and computed tomography imaging,
and electrophysiological procedures.

Case report
The patient is a 29-year-old woman born with tetralogy of Fallot and underwent transannular patch repair at 2 years of age
with no subsequent surgical or catheter-based interventions.
Additional medical history includes a seizure disorder that
was controlled using levetiracetam; she has been free of seizures for 3 years and discontinued levetiracetam last year.
She presented to the adult congenital heart disease clinic after
an episode of syncope during work in the context of her ﬁrst
trimester of pregnancy. Her pregnancy has been uncompliKEYWORDS Pacemaker; Pregnancy; Tetralogy of Fallot; Electrophysiology
study; Sick sinus syndrome
(Heart Rhythm Case Reports 2017;3:490–492)
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cated except for mild nausea and vomiting. Before the
syncopal event, she had a history of palpitations with exertion.
An electrocardiogram demonstrated normal sinus rhythm
with complete right bundle branch block (QRS duration 120
ms) and a corrected QT interval of 450 ms. An echocardiogram demonstrated free pulmonary insufﬁciency, a severely
dilated right ventricle (RV), and normal biventricular systolic
function. Cardiac magnetic resonance imaging showed an
RV end-diastolic volume of 261 mL (155 mL/m2) and an
RV ejection fraction of 40%, both unchanged compared to
a cardiac magnetic resonance imaging 3 years ago. A ZIO
Patch event monitor (iRhythm Technologies, Inc., San Francisco, CA) was placed because of complaints of dizziness.
Her syncopal event was captured on the event monitor, which
documented 7-second sinus arrest. She was diagnosed with
sick sinus syndrome and agreed to the placement of a transvenous pacemaker.

Procedural summary
The patient was brought to the electrophysiology suite and
sedated with midazolam and propofol by cardiac anesthesia;
the decision to avoid intubation or general anesthesia was
made by the interdisciplinary team. Her left pectoral region
was prepped and draped in the usual sterile fashion. Left
subclavian venous access was obtained using anatomical
landmarks without the aid of ﬂuoroscopic guidance. A 9-F
tear-away sheath was inserted into the left subclavian vein using the modiﬁed Seldinger technique. A deﬂectable mapping
catheter (Biosense Webster, Inc., Diamond Bar, CA) was
then advanced and used to create 3D electroanatomic maps
of the right atrium, RV, and coronary sinus (Figure 1). After
detailed intracardiac anatomy was deﬁned, the ablation catheter was removed. A transvenous pacemaker lead (CapsureFix model 4076, Medtronic, Inc., Minneapolis, MN) was
connected via alligator clips to the CARTO-3 system, allowing for the visualization of the lead tip on the electroanatomic
map. The lead was maneuvered toward the RV apex without
the need for ﬂuoroscopic guidance (Figure 2A and
Supplemental Video 1).
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KEY TEACHING POINTS
 Three-dimensional electroanatomic mapping
software can be used to place transvenous pacing
systems in patients with complex congenital heart
disease, negating the need for ionizing radiation.
 Ionizing radiation should be avoided during
pregnancy because of the increased risk to the
developing fetus.
 Three-dimensional electroanatomic mapping
software clearly has beneﬁts beyond
electrophysiology studies and ablation.
After proper positioning, the lead was ﬁxated to the ventricular endocardium and tension placed on the lead to ensure
that it was properly engaged while monitoring the lead tip on
CARTO. A deep breath was given to conﬁrm adequate lead
tip stability. Sensing and pacing thresholds were excellent,
with normal impedance and lack of diaphragmatic stimulation with high-output testing. The lead was connected to a
generator and placed in a left prepectoral pocket; devicebased testing conﬁrmed normal electrical parameters and
lead stability. With lead aprons under and over the patient’s
abdomen, ,1 second of ﬂuoroscopy was used to document
proper location of the pacemaker lead with sufﬁcient slack
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for patient movement (Figure 2B). In retrospect, this was
probably unnecessary but an extra precaution since it is a
novel technique for lead implantation. The patient had an uncomplicated procedure and recovery.

Discussion
Fluoroscopy typically is used for the placement of a transvenous pacing system; we were able to perform nonﬂuoroscopic mapping to avoid patient and fetal exposure to
ionizing radiation. There are previous reports of device implantation without ﬂuoroscopy, using either transesophageal
echocardiography or 3D electroanatomic mapping.4–7
However, none of these were performed on a pregnant
patient with repaired congenital heart disease, although this
has been suggested.8 This successful and uncomplicated procedure is encouraging.
A single-chamber device was chosen to decrease procedure time, simplify the procedure in a pregnant patient with
infrequent symptomatic events and predominantly intact
atrioventricular conduction, and reduce the risk of complications from the implantation and ﬁxation of an additional lead.

Conclusion
We present a unique report of a nonﬂuoroscopic transvenous
pacemaker placement in a pregnant patient with repaired
congenital heart disease. The use of electroanatomic mapping

Figure 1 Series of catheter manipulations using the CARTO-3 3-dimensional electroanatomic mapping software in the right anterior oblique and left anterior
oblique views. A: The lead begins in the innominate vein near the superior vena cava–right atrium (SVC-RA) junction. B: The lead is advanced into the RA, and
the soft stylet is exchanged for a curved stylet to facilitate crossing the tricuspid valve. C: The lead is visualized crossing the tricuspid valve. D: The lead advances
to the right ventricular outﬂow tract (RVOT), which is conﬁrmed on CARTO-3 imaging in addition to the induction of premature ventricular complexes. LIV 5
left innominate vein; RV 5 right ventricle.
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Figure 2 A: Right anterior oblique and left anterior oblique images obtained using the CARTO-3 3-dimensional electroanatomic mapping software, demonstrating ﬁnal catheter placement for lead placement. B: Fluoroscopic ﬂash image 0.5 seconds, conﬁrming lead position and adequate slack. A loop is seen, and the
tip appears to be at the right ventricular apex. RV 5 right ventricle; RVOT 5 right ventricular outﬂow tract.

allowed for the visualization of the pacemaker lead to ensure
proper location in the RV apex before and after endocardial
ﬁxation. While further experience is required before widespread use in patients with congenital heart disease,
ﬂuoroscopy-free pacemaker implantation using electroanatomic mapping may follow the course of catheter ablation
procedures and transition from a safe and effective casereportable option to eventually becoming the standard of
care.

Appendix
Supplementary data
Supplementary data associated with this article can be found
in the online version at http://dx.doi.org/10.1016/j.hrcr.2017.
07.020
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